List of Contents

Pharmaceutical Temperature Controlled Packaging Solutions Market Size, Share, and Trends 2024 to 2034

Pharmaceutical Temperature Controlled Packaging Solutions Market Size, Share & Trends Analysis Report by Type (Reusable Solutions and Single Use Solutions), By Application (Temperature-Sensitive Pharmaceuticals, Vaccines, Others) By Region, And Segment Forecasts, 2024 - 2033

  • Last Updated : February 2024
  • Report Code : 1163
  • Category : Packaging

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis

5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers

Chapter 7. Global Pharmaceutical Temperature Controlled Packaging Solutions Market, By Product

7.1. Pharmaceutical Temperature Controlled Packaging Solutions Market, by Product Type, 2024-2033
7.1.1. Reusable Solutions
7.1.1.1. Market Revenue and Forecast (2021-2033)
7.1.2. Single Use Solutions
7.1.2.1. Market Revenue and Forecast (2021-2033)

Chapter 8. Global Pharmaceutical Temperature Controlled Packaging Solutions Market, By Application

8.1. Pharmaceutical Temperature Controlled Packaging Solutions Market, by Application, 2024-2033
8.1.1. Temperature-Sensitive Pharmaceuticals
8.1.1.1. Market Revenue and Forecast (2021-2033)
8.1.2. Vaccines
8.1.2.1. Market Revenue and Forecast (2021-2033)
8.1.3. Others
8.1.3.1. Market Revenue and Forecast (2021-2033)

Chapter 9. Global Pharmaceutical Temperature Controlled Packaging Solutions Market, Regional Estimates and Trend Forecast

9.1. North America
9.1.1. Market Revenue and Forecast, by Product (2021-2033)
9.1.2. Market Revenue and Forecast, by Application (2021-2033)
9.1.3. U.S.
9.1.3.1. Market Revenue and Forecast, by Product (2021-2033)
9.1.3.2. Market Revenue and Forecast, by Application (2021-2033)
9.1.4. Rest of North America
9.1.4.1. Market Revenue and Forecast, by Product (2021-2033)
9.1.4.2. Market Revenue and Forecast, by Application (2021-2033)
9.2. Europe
9.2.1. Market Revenue and Forecast, by Product (2021-2033)
9.2.2. Market Revenue and Forecast, by Application (2021-2033)
9.2.3. UK
9.2.3.1. Market Revenue and Forecast, by Product (2021-2033)
9.2.3.2. Market Revenue and Forecast, by Application (2021-2033)
9.2.4. Germany
9.2.4.1. Market Revenue and Forecast, by Product (2021-2033)
9.2.4.2. Market Revenue and Forecast, by Application (2021-2033)
9.2.5. France
9.2.5.1. Market Revenue and Forecast, by Product (2021-2033)
9.2.5.2. Market Revenue and Forecast, by Application (2021-2033)
9.2.6. Rest of Europe
9.2.6.1. Market Revenue and Forecast, by Product (2021-2033)
9.2.6.2. Market Revenue and Forecast, by Application (2021-2033)
9.3. APAC
9.3.1. Market Revenue and Forecast, by Product (2021-2033)
9.3.2. Market Revenue and Forecast, by Application (2021-2033)
9.3.3. India
9.3.3.1. Market Revenue and Forecast, by Product (2021-2033)
9.3.3.2. Market Revenue and Forecast, by Application (2021-2033)
9.3.4. China
9.3.4.1. Market Revenue and Forecast, by Product (2021-2033)
9.3.4.2. Market Revenue and Forecast, by Application (2021-2033)
9.3.5. Japan
9.3.5.1. Market Revenue and Forecast, by Product (2021-2033)
9.3.5.2. Market Revenue and Forecast, by Application (2021-2033)
9.3.6. Rest of APAC
9.3.6.1. Market Revenue and Forecast, by Product (2021-2033)
9.3.6.2. Market Revenue and Forecast, by Application (2021-2033)
9.4. MEA
9.4.1. Market Revenue and Forecast, by Product (2021-2033)
9.4.2. Market Revenue and Forecast, by Application (2021-2033)
9.4.3. GCC
9.4.3.1. Market Revenue and Forecast, by Product (2021-2033)
9.4.3.2. Market Revenue and Forecast, by Application (2021-2033)
9.4.4. North Africa
9.4.4.1. Market Revenue and Forecast, by Product (2021-2033)
9.4.4.2. Market Revenue and Forecast, by Application (2021-2033)
9.4.5. South Africa
9.4.5.1. Market Revenue and Forecast, by Product (2021-2033)
9.4.5.2. Market Revenue and Forecast, by Application (2021-2033)
9.4.6. Rest of MEA
9.4.6.1. Market Revenue and Forecast, by Product (2021-2033)
9.4.6.2. Market Revenue and Forecast, by Application (2021-2033)
9.5. Latin America
9.5.1. Market Revenue and Forecast, by Product (2021-2033)
9.5.2. Market Revenue and Forecast, by Application (2021-2033)
9.5.3. Brazil
9.5.3.1. Market Revenue and Forecast, by Product (2021-2033)
9.5.3.2. Market Revenue and Forecast, by Application (2021-2033)
9.5.4. Rest of LATAM
9.5.4.1. Market Revenue and Forecast, by Product (2021-2033)
9.5.4.2. Market Revenue and Forecast, by Application (2021-2033)

Chapter 10. Company Profiles

10.1. Pelican Biothermal
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. Cryopak
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. Sonoco Products Company
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. Envirotainer
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. DS Smith Pharma
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. Cold Chain Technologies
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. World Courier
10.7.1. Company Overview
10.7.2. Product Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8. Intelsius
10.8.1. Company Overview
10.8.2. Product Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives
10.9. CSafe
10.9.1. Company Overview
10.9.2. Product Offerings
10.9.3. Financial Performance
10.9.4. Recent Initiatives
10.10. Softbox Systems
10.10.1. Company Overview
10.10.2. Product Offerings
10.10.3. Financial Performance
10.10.4. Recent Initiatives
10.11. Skycell
10.11.1. Company Overview
10.11.2. Product Offerings
10.11.3. Financial Performance
10.11.4. Recent Initiatives
10.12. Va-Q-tec AG
10.12.1. Company Overview
10.12.2. Product Offerings
10.12.3. Financial Performance
10.12.4. Recent Initiatives
10.13. Sofrigam
10.13.1. Company Overview
10.13.2. Product Offerings
10.13.3. Financial Performance
10.13.4. Recent Initiatives

Chapter 11. Research Methodology

11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions

Chapter 12. Appendix

12.1. About Us
12.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The pharmaceutical temperature controlled packaging solutions market size was valued at USD 5.53 billion in 2023 and market to reach USD 10.8 billion by 2033.

Implementation of novel high-performance convection systems that are well-organized for warehousing and supply of pharmaceutical products is anticipated to provide novel growth prospect to the pharmaceutical temperature-controlled packaging solutions industry. Increasing practice of vacuum panel insulation along with the phase change materials can augment the life of warehoused pharmaceutical product. Consequently, the intensifying adoption of such progressive technologies in the pharmaceutical sector is projected to subsidize the growth of the market worldwide.

North America is predicted to occupy major stake in the global pharmaceutical temperature-controlled packaging solutions market. This region is likely to have a pool of large market players and more usage of pharmaceutical temperature-controlled products in the Canada and U.S. Further, the Asia Pacific excluding Japan (APEJ) region is expected to observe high growth latent for pharmaceutical temperature-controlled packaging solutions.

In 2023, reusable temperature controlled pharmaceutical solution dominated the global market with around 65.47% share in terms of revenue.

Temperature-sensitive pharmaceutical applications led the global pharmaceutical temperature-controlled solution market with more than 60.27% share in 2023. The effort of addressing more and more patients present in distant locations is predictable to support the requirement for pharmaceuticals temperature-controlled packaging solutions across the world.

Crucial players operating in the arena of global pharmaceuticals temperature-controlled packaging solutions are Pelican Biothermal, Sonoco, Sofrigam SA Ltd., Cryopak, Inmark Packaging, Cold Chain Technologies, VA-Q-Tec AG, Envirotainer Ltd., and American Aerogel Corporation among others.

Pharmaceuticals temperature-controlled packaging solution is an imperative tool in plummeting the hazard and upholding quality of product during the supply chain process by steadying internal temperature. This system benefits to protect shipments across each aspect of the medical supply chain. Some of the foremost application areas of temperature-controlled packaging solutions include inactive pharmaceutical ingredients with balanced temperature, vaccines, biological products and samples, clinical trials, and medical products with detailed timeline necessities.

Proceed To Buy

USD 4900
USD 3800
USD 2100
USD 2100
USD 7500
* Immediate Delivery Available

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client

down-arrow-imgGet a Sample

Connect with us now; your solution awaits on the other side!

Contact Us